ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15

Table 1 Expression of ZNF703 in different types of ovarian tissue

Group	Cases	Low		High		Positive rate(%)	High Positive rate(%)
Group	Cases	–	+	++	+++	Positive rate(%)	High Positive rate(%)
Malignant	98	15	24	28	31	84.7^a,b	60.2^c,d
Borderline	15	5	5	3	2	66.7^e,f	33.3^g,h
Benign	14	7	5	2	0	50	14.3
Normal	12	9	3	0	0	25	0

Note: a, malignant vs. benign (**, P = 0.006); b, malignant vs. normal (***, P < 0.001); c, malignant vs. benign (***, P < 0.001); d, malignant vs. normal (***, P < 0.001); e, borderline vs. benign (P = 0.362); f, borderline vs. normal (*, P = 0.031); g, borderline vs. benign (P = 0.39); h, borderline vs. normal (*, P = 0.047)

ISSN: 1756-9966